Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
4.920
+0.100 (2.07%)
At close: Nov 26, 2025, 4:00 PM EST
4.850
-0.070 (-1.42%)
After-hours: Nov 26, 2025, 7:59 PM EST
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $130.39 million as of November 26, 2025. Its market cap has increased by 23.54% in one year.
Market Cap
130.39M
Enterprise Value
115.11M
1-Year Change
23.54%
Ranking
Category
Stock Price
$4.92
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has increased from $62.51M to $130.39M, an increase of 108.60%. That is a compound annual growth rate of 13.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 130.39M | 87.89% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | 51.96M | -16.87% |
| Jan 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |